Stock CLOV CLOVER HEALTH INVESTMENTS, CORP.
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Clover Health Investments, Corp.

Equities

CLOV

US18914F1030

Market Closed - Nasdaq
Other stock markets
 21:00:00 26/04/2024 BST 		5-day change 1st Jan Change
0.68 USD +1.49% Intraday chart for Clover Health Investments, Corp. +6.99% -28.58%
04-22 Clover Health Investments, Corp. Announces the Appointment of Peter Kuipers as Chief Financial Officer CI
03-19 Clover Health Launches New Clinical Program in Partnership with quarter Health to Address Serious Mental Illness CI

Strengths

  • The company shows low valuation levels, with an enterprise value at 0.2 times its sales.
  • The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
  • Consensus analysts have strongly revised their opinion of the company over the past 12 months.

Weaknesses

  • According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
  • The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
  • The company has insufficient levels of profitability.
  • For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
  • The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
  • For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
  • The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.

Ratings chart - Surperformance

Sector: Managed Healthcare

1st Jan change Capi. Investor Rating ESG Refinitiv
CLOVER HEALTH INVESTMENTS, CORP. Stock Clover Health Investments, Corp.
-28.58% 337M -
UNITEDHEALTH GROUP INC. Stock UnitedHealth Group Inc.
-5.91% 456B
B-
ELEVANCE HEALTH, INC. Stock Elevance Health, Inc.
+13.93% 125B
A-
CIGNA Stock Cigna
+18.37% 101B
B-
CENTENE CORPORATION Stock Centene Corporation
-0.28% 39.69B
B-
HUMANA INC. Stock Humana Inc.
-33.18% 36.86B
A-
MOLINA HEALTHCARE, INC. Stock Molina Healthcare, Inc.
-5.28% 20.05B
B-
PROGYNY, INC. Stock Progyny, Inc.
-13.82% 3.08B
C+
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
-
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
-
EV / Sales
Price to Book
-
Price to Free Cash Flow
-
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. CLOV Stock
  4. Ratings Clover Health Investments, Corp.